Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART

A 27-year-old male with HIV-associated naïve and high-risk Burkitt’s lymphoma sequentially received short-term, high-dose non-myeloablative chemotherapy and autologous CD34-positive stem cell transfusion in the setting of combined antiretroviral therapy (cART). Prompt hematopoietic recovery was obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Haiyan, Yang, Jianwei, Wang, Sanbin, Tao, Pengfei, Song, Yuqin, Wang, Xiaopei, Li, Huiqin, Yang, Xinping, Dong, Xingqi, Wang, Fu-Sheng, Shi, Ming, Wang, Xicheng, Xu, Ruonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302511/
https://www.ncbi.nlm.nih.gov/pubmed/30572947
http://dx.doi.org/10.1186/s13287-018-1089-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302511/
https://www.ncbi.nlm.nih.gov/pubmed/30572947
http://dx.doi.org/10.1186/s13287-018-1089-5

Ejemplares similares